SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 319 filers reported holding SALIX PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.43 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $7,051,000 | +45.7% | 40,800 | -3.1% | 0.10% | +47.0% |
| Q4 2014 | $4,839,000 | -28.1% | 42,100 | -2.3% | 0.07% | -29.8% |
| Q3 2014 | $6,734,000 | +26.1% | 43,100 | -0.5% | 0.09% | +27.0% |
| Q2 2014 | $5,341,000 | +16.4% | 43,300 | -2.3% | 0.07% | +13.8% |
| Q1 2014 | $4,590,000 | +15.2% | 44,300 | 0.0% | 0.06% | +14.0% |
| Q4 2013 | $3,984,000 | +29.8% | 44,300 | -3.5% | 0.06% | +21.3% |
| Q3 2013 | $3,070,000 | +0.9% | 45,900 | -0.2% | 0.05% | 0.0% |
| Q2 2013 | $3,043,000 | – | 46,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $34,482,000 | 18.91% |
| NORTH RUN CAPITAL, LP | 490,000 | $56,321,000 | 5.02% |
| Visium Asset Management, LP | 3,076,092 | $353,568,000 | 4.99% |
| BOW STREET LLC | 112,979 | $12,986,000 | 4.60% |
| 1492 Capital Management LLC | 62,397 | $7,172,000 | 4.49% |
| CLOVIS CAPITAL MANAGEMENT LP | 115,000 | $13,218,000 | 3.70% |
| Paulson & Co. | 5,806,000 | $667,342,000 | 3.45% |
| HealthCor Management, L.P. | 525,000 | $60,344,000 | 3.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 158,500 | $18,218,000 | 3.10% |
| AMI ASSET MANAGEMENT CORP | 299,276 | $34,399,000 | 3.01% |